Top Harvest Capital

Youlify is a company that specializes in AI-driven solutions for medical billing and revenue cycle management. Its platform is designed to assist medical practices in improving their billing and collections processes by offering an AI-powered onboarding approach that enhances payment efficiency. Additionally, Youlify provides tools for investigating denied claims and delivers real-time financial insights and analytics. This enables healthcare providers to appeal denied claims effectively, increasing their chances of successful resolution. Overall, Youlify focuses on leveraging artificial intelligence to optimize financial operations within the medical sector.

Voxel51, Inc. is an AI software company based in Ann Arbor, Michigan, founded in 2016. The company specializes in computer vision and machine learning analytics, focusing on the understanding of video and image data. Voxel51's technology transforms raw video footage and images into actionable intelligence, utilizing machine learning to process and label content based on image recognition and the analysis of motions and objects over time. This enables data scientists in the field of computer vision to efficiently curate, explore, and test datasets alongside their models, facilitating the development of production-ready visual AI solutions.

Leash Biosciences engages in machine learning to solve medicinal chemistry.

Bioptimus is a biotechnology company focused on developing a universal artificial intelligence foundation model that integrates various scales of biology, from molecules to cells, tissues, and entire organisms. The company's innovative technology leverages generative AI to transform complex multiscale biological data into actionable insights, facilitating significant advancements in scientific research and biomedical innovation. By enabling clients to effectively harness this data, Bioptimus aims to drive breakthrough discoveries and enhance the efficiency of biotechnological processes.

Vectara is a developer of a generative AI product platform that enables businesses to integrate advanced AI features into their applications. The company offers an end-to-end serverless Retrieval Augmented Generation (RAG) API platform, which provides a secure and efficient way to incorporate conversational AI and question-answering capabilities. Vectara's platform is built on a hybrid-search core, ensuring accurate and reliable results that are grounded in the specific data and knowledge of the organization. It addresses critical challenges associated with enterprise adoption, such as reducing hallucination, enhancing explainability, enforcing access control, and allowing for real-time updates of knowledge. Additionally, Vectara's platform supports multilingual capabilities and prioritizes data security, making it suitable for various applications including semantic search, research analysis, and conversational AI, thus enabling organizations to create experiences similar to ChatGPT.

Inato is a Paris-based company, founded in 2016, that specializes in automating the processes involved in launching clinical trials for life science companies. With additional offices in New York and London, Inato offers an AI-powered platform that streamlines data collection and analysis, enabling pharmaceutical companies to significantly reduce drug development costs and expedite the clinical trial process. The company operates a global marketplace that connects pharmaceutical firms with a diverse range of community research sites, enhancing access to clinical trials for patients while promoting inclusivity and efficiency in clinical research. By facilitating collaborative enrollment planning and providing ongoing support, Inato ensures that research sites can effectively deliver trials, allowing healthcare professionals to identify and select suitable research opportunities more efficiently. Through its innovations, Inato aims to accelerate the delivery of new therapies to patients at lower costs.

Asaren manages the mental health needs of their blue-chip clients' employees, with industries ranging from banking, energy, retail, and many others. They provide triage assessment, DNA testing, and online consultation with medical professionals.

Rembrand is an advertising agency specializing in a comprehensive range of marketing services, including brand strategy, campaign management, and social media marketing. The company offers digital marketing solutions such as content marketing, newsletter, display advertising, and employer branding. Additionally, Rembrand has developed a programmatic product placement platform that utilizes generative AI to enhance videos with virtual product placements, allowing brands to connect seamlessly with creators to scale their marketing efforts. This innovative approach to monetizing videos without interruptive ads positions Rembrand as a forward-thinking player in the advertising landscape.

Vectara is a developer of a generative AI product platform that enables businesses to integrate advanced AI features into their applications. The company offers an end-to-end serverless Retrieval Augmented Generation (RAG) API platform, which provides a secure and efficient way to incorporate conversational AI and question-answering capabilities. Vectara's platform is built on a hybrid-search core, ensuring accurate and reliable results that are grounded in the specific data and knowledge of the organization. It addresses critical challenges associated with enterprise adoption, such as reducing hallucination, enhancing explainability, enforcing access control, and allowing for real-time updates of knowledge. Additionally, Vectara's platform supports multilingual capabilities and prioritizes data security, making it suitable for various applications including semantic search, research analysis, and conversational AI, thus enabling organizations to create experiences similar to ChatGPT.

Voxel51, Inc. is an AI software company based in Ann Arbor, Michigan, founded in 2016. The company specializes in computer vision and machine learning analytics, focusing on the understanding of video and image data. Voxel51's technology transforms raw video footage and images into actionable intelligence, utilizing machine learning to process and label content based on image recognition and the analysis of motions and objects over time. This enables data scientists in the field of computer vision to efficiently curate, explore, and test datasets alongside their models, facilitating the development of production-ready visual AI solutions.

Hedera Dx is a healthcare company established on July 1, 2021, in Epalinges, Vaud, specializing in liquid biopsy solutions aimed at enhancing cancer detection and treatment. The company's innovative system enables hospital laboratories to perform clinically useful liquid biopsies independently, simplifying the process of tumor profiling. By addressing challenges related to compliance, privacy, and validation, Hedera Dx offers a streamlined experience for clinicians, facilitating early detection, therapy selection, and monitoring of cancer recurrence. This technology not only aids in reducing cancer risks but also presents opportunities to lower mortality rates and healthcare costs.

Kinetix is a company founded in 2020 and based in Paris, France, that focuses on empowering self-expression in the Metaverse through artificial intelligence and no-code tools. It provides solutions that enable users to easily create 3D animations, making this technology accessible to a broader audience. Kinetix leverages advancements in AI to streamline the animation process, allowing individuals without technical expertise to engage in creative activities within virtual environments. Its mission centers on democratizing the creation of digital content, contributing to the evolving landscape of the Metaverse and enhancing the ways in which users can communicate and express themselves digitally.

Mindmesh is a software developer focused on enhancing communication and efficiency for product-oriented teams and managers. The company provides a knowledge base tool that addresses challenges related to context switching and information fragmentation. Its innovative interface centralizes actionable insights from various sources, including notes, tasks, and calendars, while integrating seamlessly with popular team collaboration tools such as Slack, Gmail, Calendar, Jira, and Drive. By facilitating the quick creation of concise documentation and enabling the search for dispersed knowledge, Mindmesh aims to foster collaboration among employees, allowing them to easily connect and access information regardless of their current tasks or locations.

MEDIC Life Sciences is a biotechnology company based in the San Francisco Bay Area, specializing in cancer drug discovery. The company utilizes a proprietary CRISPR functional genomics platform to develop synergistic drug combinations for cancer treatment. By employing advanced 3D tumor models, MEDIC accurately captures tumor suppressor and oncogene phenotypes, systematically integrating CRISPR variants that mimic cancer mutations. This innovative approach allows for comprehensive measurement of drug associations with various mutations, ultimately enabling healthcare companies to create effective therapeutic options for treating tumors and other related diseases.

Mantium is a secure cloud-based data platform that facilitates software developers in accessing, transforming, and enriching data using large language models while ensuring data privacy and security. The platform offers a no-code solution that streamlines workflows through automated data preparation, which includes capabilities for transforming, cleaning, and enriching data from diverse sources. By enabling the creation of various datasets and managing data pipelines and infrastructure, Mantium accelerates the artificial intelligence journey for its clients, effectively supporting them in the initial stages of the AI development process.

Hedera Dx is a healthcare company established on July 1, 2021, in Epalinges, Vaud, specializing in liquid biopsy solutions aimed at enhancing cancer detection and treatment. The company's innovative system enables hospital laboratories to perform clinically useful liquid biopsies independently, simplifying the process of tumor profiling. By addressing challenges related to compliance, privacy, and validation, Hedera Dx offers a streamlined experience for clinicians, facilitating early detection, therapy selection, and monitoring of cancer recurrence. This technology not only aids in reducing cancer risks but also presents opportunities to lower mortality rates and healthcare costs.